title: Intralesional cidofovir in the treatment of cutaneous warts in a renal transplant patient.
abstract: BACKGROUND
  Cutaneous warts are often recalcitrant to conventional therapy in immunocompromised patients. Cidofovir is a potent antiviral agent shown to have a broad spectrum of action against DNA virus, including human papillomavirus.
  
  
  OBJECTIVE
  To determine the efficacy of intralesional cidofovir in the treatment of florid warts in an immunocompromised renal transplant patient.
  
  
  METHODS
  The patient received seven injections of intralesional cidofovir at 4 week intervals in his numerous palmar warts.
  
  
  CONCLUSIONS
  Based on our results, intralesional cidofovir is a promising therapeutic modality in the treatment of cutaneous warts in the renal transplant population.
authors.affiliation: Divisions of Dermatology and Nephrology, Department of Medicine, Centre Hospitalier Universitaire de Québec, Laval University, Quebec, QC. marie-michele. blouin.2@ulaval.ca
authors.forename: Marie-Michèle
authors.initials: MM
authors.lastname: Blouin
authors.forename: Richard
authors.initials: R
authors.lastname: Cloutier
authors.forename: Réal
authors.initials: R
authors.lastname: Noël
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000077404:Cidofovir; D003596:Cytosine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006229:Hand Dermatoses / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D016867:Immunocompromised Host; D015552:Injections, Intralesional; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D063065:Organophosphonates / Q000008:administration & dosage / Q000627:therapeutic use*; D014860:Warts / Q000188:drug therapy* / Q000821:virology; D055815:Young Adult
chemical_list: D000998:Antiviral Agents; D063065:Organophosphonates; D003596:Cytosine; D000077404:Cidofovir